|
Schlusskurs
Korea S.E.
25.08.2026
|
% 5 Tage | Veränd. 1. Jan. | ||
| 189’600.00 KRW | -2.27% |
|
-3.02% | +9.99% |
| 25.08. | Celltrion bringt Omlyclo in der Wirkstärke 300 mg in wichtigen europäischen Märkten auf den Markt | CI |
| 24.08. | Celltrion reicht Zulassungsantrag für Keytruda-Biosimilar in Südkorea ein | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.27% | -3.02% | +6.76% | +0.19% | +9.99% | +14.22% | +51.50% | -18.22% | +145.06% | 33.48 Mrd. | |
| -0.07% | -0.20% | +4.50% | +17.67% | +8.70% | +2.13% | +22.94% | -24.84% | +213.29% | 50.96 Mrd. | |
| +1.92% | +0.36% | +13.85% | +39.09% | +170.48% | +477.97% | +550.09% | +685.70% | - | 46.18 Mrd. | |
| -0.15% | -0.28% | +15.31% | +24.26% | +23.70% | +21.65% | +89.41% | +32.88% | +1’242.62% | 42.73 Mrd. | |
| +0.81% | +4.91% | +25.70% | +61.43% | +16.02% | +39.28% | +19.41% | +1.17% | +245.50% | 43.04 Mrd. | |
| +0.81% | +1.77% | +2.94% | +44.26% | +10.22% | +31.91% | +138.26% | +244.51% | +2’181.79% | 17.28 Mrd. | |
| -1.08% | -3.61% | -1.42% | +4.42% | - | - | - | - | - | 16.43 Mrd. | |
| -0.30% | -0.22% | +8.58% | +16.33% | +16.44% | +11.51% | +28.28% | -38.87% | +97.90% | 14.73 Mrd. | |
| -0.85% | +1.76% | +30.24% | +88.29% | +47.93% | +80.26% | +47.26% | -32.57% | +255.07% | 14.09 Mrd. | |
| +0.01% | -2.06% | +1.91% | +48.38% | -7.29% | -1.65% | -34.09% | -33.23% | +124.37% | 13.03 Mrd. | |
| -0.36% | +11.80% | +60.41% | +46.76% | +15.97% | -10.25% | - | - | - | 12.36 Mrd. | |
| +3.48% | -9.25% | +20.48% | +79.99% | +63.28% | +45.88% | +63.80% | -46.57% | - | 11.12 Mrd. | |
| +0.07% | -0.14% | +1.09% | +50.89% | +23.07% | +27.45% | -9.71% | -41.30% | +173.96% | 11.35 Mrd. | |
| +1.00% | +1.20% | -10.42% | -9.79% | -15.78% | +47.38% | +472.23% | +247.26% | +2’379.22% | 10.94 Mrd. | |
| -0.33% | +4.21% | +12.04% | -16.71% | -19.91% | +50.25% | +57.14% | +62.88% | +105.05% | 10.53 Mrd. | |
| -0.86% | -1.38% | +13.55% | +55.44% | +61.35% | +186.19% | +539.26% | +114.43% | - | 10.44 Mrd. | |
| +2.54% | -2.28% | +16.01% | +7.64% | +28.03% | +687.83% | +1’577.20% | +38.84% | - | 10.54 Mrd. | |
| +0.07% | +0.18% | +0.50% | +62.96% | +78.79% | +256.35% | +468.21% | - | - | 10.18 Mrd. | |
| +0.45% | +6.29% | +110.82% | +133.91% | +185.51% | +104.50% | +90.65% | -4.42% | +1’638.24% | 9.86 Mrd. | |
| +0.60% | -2.22% | +11.31% | +51.53% | +73.46% | +165.84% | +660.54% | +221.31% | +1’351.15% | 9.8 Mrd. | |
| Durchschnitt | +0.15% | +1.67% | +17.21% | +40.35% | +41.58% | +117.83% | +268.47% | +82.88% | +781.02% | 19.95 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.05% | +1.38% | +14.98% | +35.66% | +42.91% | +113.16% | +207.22% | +111.40% | +646.71% |
- Börse
- Aktien
- A068270 Aktie
- Sektor Celltrion, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
